Journal of Inherited Metabolic Disease

, Volume 28, Issue 6, pp 831–843 | Cite as

State regulation and response inhibition in children with ADHD and children with early- and continuously treated phenylketonuria: An event-related potential comparison

  • J. R. Wiersema
  • J. J. van der Meere
  • H. Roeyers
Article

Summary

Background: The presentation rate of stimuli plays an important role in explaining the performance inefficiency in children with ADHD. In general, children with ADHD have been found to perform more poorly in conditions of relatively slow event rates as compared with fast and moderate event rates. The state regulation hypothesis states that these children have problems in correcting their energetic state necessary to counteract a performance decrement, which requires extra effort allocation. In this study, we investigated state regulation in children with ADHD and used children with early- and continuously treated phenylketonuria (PKU) as a clinical contrast group. Method: We measured the parietal P3 during a Go/No-Go task that incorporated a condition with a fast and a slow presentation rate. Results: We were able to show that children with ADHD, relative to controls, responded more slowly and more variably in the slow condition only, which was accompanied by a smaller P3, suggesting less effort allocation. In contrast, the children with PKU did not show a state regulation deficit. The PKU group showed prolonged stimulus evaluation processing, as indexed by P3 latency, compared to controls and children with ADHD. In addition, they made more errors of commission than the controls and the ADHD group. Conclusions: Our electrophysiological data support the state regulation hypothesis of ADHD. Only the children with PKU had more problems in inhibiting pre-potent responding than controls, which is in accord with the prefrontal dysfunction hypothesis of PKU.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Achenbach TM, Edelbrock CS (1983) Manual for the Child Behavior Checklist and Revised Child Behavior Profile. Burlington, Vermont: University of Vermont, Department of Psychiatry.Google Scholar
  2. Achenbach TM, Edelbrock CS (1986) Manual for the Teacher's Report Form and Teacher Version of the Child Behavior Profile. Burlington, Vermont: University of Vermont, Department of Psychiatry.Google Scholar
  3. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text revision. Washington DC: American Psychiatic Association.Google Scholar
  4. Arnold GL, Vladutiu CJ, Orlowski CC, Blakely EM, DeLuca J (2004) Prevalence of stimulant use for attentional dysfunction in children with pehylketonuria. J Inherit Metab Dis 27: 137–143.PubMedCrossRefGoogle Scholar
  5. Arnsten AFT (2000) Genetics of childhood disorders: XVIII. ADHD, Part 2: Norepinephrine has a critical modulatory influence on prefrontal cortical function. J Am Acad Child Psychiatry 39: 1201–1203.Google Scholar
  6. Banich MT, Passarotti AM, White DA, Nortz MJ, Steiner RD (2000) Interhemisperic interaction during childhood: II. Children with early-treated phenylketonuria. Dev Neuropsychol 18: 53–71.PubMedGoogle Scholar
  7. Barkley RA (1997) Behavioral inhibition, sustained attention and executive functions: constructing a unifying theory of ADHD. Psychol Bull 121: 65–94.PubMedCrossRefGoogle Scholar
  8. Barkley RA (2000) Genetics of childhood disorders: XVII. ADHD, Part 1: The executive functions and ADHD. J Am Acad Child Psychiatry 39: 1064–1068.Google Scholar
  9. Bradberry CW, Karasic DH, Deutch AY, Roth RH (1989) Regionally-specific alterations in mesotelencephalic dopamine synthesis in diabetic rats: association with precursor tyrosine. J Neural Transm 78: 221–229.CrossRefGoogle Scholar
  10. Burgard P (2000) Development of intelligence in early treated phenylketonuria. Eur J Pediatr 159: S74–S79.PubMedGoogle Scholar
  11. Burgard P, Rey F, Rupp A, Abadie V, Rey J (1997) Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: results of a cross-national and cross-sectional study. Pediatr Res 41: 368–374.PubMedGoogle Scholar
  12. Diamond A (1994) Phenylalanine levels of 6–10 mg/dl may not be as benign as once thought. Acta Paediatr 83: 89–91.Google Scholar
  13. Diamond A, Prevor MB, Callender G, Druin DP (1997) Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monogr Soc Res Child 62.Google Scholar
  14. Donchin E, Coles MGH (1988) Is the P300 component a manifestation of context updating? Behav Brain Sci 11: 355–372.Google Scholar
  15. Donchin E, Kramer AF, Wickens C (1986) Applications of brain event-related potentials to problems in engineering psychology. In: Coles MGH, Donchin E, Porges S, eds. Psychophysiology: Systems, Processes and Applications, Middletown, NJ: Till & Till, 702–718.Google Scholar
  16. Eimer M (1993) Effects of attention and stimulus probability on ERPs in a Go/Nogo task. Biol Psychology 35: 123–138.Google Scholar
  17. Falkenstein M, Hoormann J, Hohnsbein J (1999) ERP components in Go/Nogo tasks and their relation to inhibition. Acta Psychiatr 101: 267–291.Google Scholar
  18. Faraone SV, Biederman J (1998) Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 44: 951–958.PubMedCrossRefGoogle Scholar
  19. Gardiner RM (1990) Transport of amino acids across the blood–brain barrier: implications for treatment of maternal phenylketonuria. J Inherit Metab Dis 13: 627–633.PubMedCrossRefGoogle Scholar
  20. Gratton G, Coles MGH, Donchin E (1983) A new method for off-line removal of ocular artifact. Electroenceph Clin Neurophys 55: 468–484.Google Scholar
  21. Henderson RM, McCulloch DL, Herbert AM, Robinson PH, Taylor MJ (2000) Visual event-related potentials in children with phenylketonuria. Acta Paediatr 89: 52–57.PubMedGoogle Scholar
  22. Hommes FA (1989) The role of the blood-brain barrier in the aetiology of permanent brain dysfunction in hyperphenylalaninemia. J Inherit Metab Dis 12: 41–46.PubMedCrossRefGoogle Scholar
  23. Huijbregts S, De Sonneville LJM, Licht R, Sergeant JA, Van Spronsen FJ (2002) Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria. Dev Neuropsych 22: 481–499.Google Scholar
  24. Huijbregts SCJ, De Sonneville LMJ, Licht R, Van Spronsen FJ, Verkerk PH, Sergeant JA (2002) Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations. Neuropsych 40: 7–15.Google Scholar
  25. Huijbregts SCJ, De Sonneville LMJ, Van Spronsen FJ, et al (2003) Motor function under lower and higher controlled processing demands in early and continuously treated phenylketonuria. Neuropsych 17: 369–379.Google Scholar
  26. Kalverboer AF, van der Schot LW, Hendrikx MM, Huisman J, Slijper FM, Stemerdink BA (1994) Social behaviour and task orientation in early-treated PKU. Acta Paediatr Suppl 407: 104–105.PubMedGoogle Scholar
  27. Knudsen GM, Hasselbalch S, Toft PB, Christensen E, Paulson OB, Lou H (1995) Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria. J Inherit Metab Dis 18: 653–664.PubMedGoogle Scholar
  28. Kok A (2001) On the utility of P3 amplitude as a measure of processing capacity. Psychophysiology 38: 557–577.PubMedCrossRefGoogle Scholar
  29. Kopp B, Mattler U, Goertz R, Rist F (1996) N2, P3 and the lateralized readiness potential in a go-nogo task involving selective response priming. Electroencephalogr Clin Neurophysiol 99: 19–27.PubMedGoogle Scholar
  30. Leuzzi V, Seri S, Cerquiglini A, Carducci C, Carducci C, Antonozzi I (2000) Derangement of the dopaminergic system in phenylketonuria: study of the event-related potential (P300). J Inherit Metab Dis 23: 317–320.PubMedGoogle Scholar
  31. Leuzzi V, Pansini M, Sechi, et al (2004) Executive function impairment in early-treated PKU subjects with normal mental development. J Inherit Metab Dis 27: 115–125.PubMedCrossRefGoogle Scholar
  32. Lou HC, Lykkelund C, Gerdes A-M, Udesen H, Bruhn P (1987) Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria. Acta Paediatr Scand 76: 560–565.Google Scholar
  33. National Institutes of Health. Consensus Development Conference Statement. Phenylketonuria: Screening and Management October 16018, 2000 (online). http://odp.od.nih.gov/consensus/cons/113/113_statement.htm
  34. Nigg JT (2001) Is ADHD a disinhibitory disorder? Psychol Bull 127: 571–598.PubMedCrossRefGoogle Scholar
  35. Oosterlaan J, Logan GD, Sergeant JA (1998) Response inhibition in AD/HD, CD, comorbid AD/HD+CD, anxious, and control children: a meta-analysis of studies with the stop task. J Child Psychol Psychiatry 39: 411–425.PubMedCrossRefGoogle Scholar
  36. Pennington BF, Ozonoff S (1996) Executive functions and developmental psychopathology. J Child Psychol Psychiatry 37: 51–87.PubMedGoogle Scholar
  37. Pietz J, Kreis R, Rupp A, et al (1999) Large neutral amino acids block transport into brain tissue in patients with phenylketonuria. J Clin Invest 103: 1169–1178.PubMedGoogle Scholar
  38. Plitszka SR, McCracken JT, Maas JW (1996) Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Psychiatry 35: 264–272.Google Scholar
  39. Polich J, Kok A (1995) Cognitive and biological determinants of P300: an integrative review. Biol Psychol 41: 103–146.PubMedCrossRefGoogle Scholar
  40. Quay HC (1997) Inhibition and attention deficit hyperactivity disorder. J Abnorm Child Psychol 25: 7–13.PubMedCrossRefGoogle Scholar
  41. Ris MD, Williams SE, Hunt MM, Berry HK, Leslie N (1994) Early-treated phenylketonuria: adult neuropsychological outcome. J Pediatr 124: 388–392.Google Scholar
  42. Sanders AF (1983) Toward a model of stress and human performance. Acta Psychol 53: 61–79.Google Scholar
  43. Sanders AF (1998) Elements of Human Performance: Reaction Processes and Attention in Human Skill. Mahwah: Lawrence Erlbaum Associates.Google Scholar
  44. Schachar R, Logan GD (1990) Impulsivity and inhibitory control in normal development and childhood psychopathology. Dev Psychol 26: 710–720.CrossRefGoogle Scholar
  45. Sergeant JA, Oosterlaan J, van der Meere JJ (1999) Information processing and energetic factors in attention-deficit/hyperactivity disorder. In: Quay HC, Hogan AE, eds. Handbook of Disruptive Behavior Disorders. New York: Plenum Press, 75–104.Google Scholar
  46. Schmidt E, Rupp A, Burgard P, Pietz J, Weglage J, De Sonneville L (1994) Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine blood-level. J Clin Exp Neuropsychol 16: 681–688.PubMedGoogle Scholar
  47. Scriver CR, Kaufman S, Eisensmith RC, Woo SLC (1995) The hyperpheylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds.; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 1025–1075.Google Scholar
  48. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME (2000) NIMH diagnostic interview schedule for children version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Psychiatr 39: 28–38.Google Scholar
  49. Singhal A, Fowler B (2004) The differential effects of Sternberg short- and long-term memory scanning on the late Nd and P300 in a dual-task paradigm. Cogn Brain Res 21: 124–132.CrossRefGoogle Scholar
  50. Smith ML, Klim P, Mallozzi E, Hanley WB (1996) A test of the frontal-specificity hypothesis in the cognitive performance of adults with phenylketonuria. Dev Neuropsychol 12: 327–341.Google Scholar
  51. Stemerdink NBA, van der Meere JJ, Van der Molen MW, et al (1995) Information processing in patients with early and continuously treated phenylketonuria. Eur J Pediatr 154: 739–746.PubMedCrossRefGoogle Scholar
  52. Stemerdink NBA, Van der Molen MW, Kalverboer AF, et al (1999) Prefrontal dysfunction in early and continuously treated phenylketonuria. Dev Neuropsychol 16: 29–57.CrossRefGoogle Scholar
  53. Stemerdink NBA, Kalverboer AF, van der Meere JJ, et al (2000) Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J Inherit Metab Dis 23: 548–562.PubMedCrossRefGoogle Scholar
  54. Swanson J, Castellanos FX, Murias M, Lahoste G, Kennedy J (1998) Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Curr Opin Neurobiol 8: 263–271.PubMedCrossRefGoogle Scholar
  55. Ullrich K, Weglage J, Oberwittler C, et al (1996) Effect of L-dopa on visual evoked potentials and neuropsychological tests in adult phenylketonuria patients. Eur J Pediatr 155: S74–S77.PubMedGoogle Scholar
  56. Ullsperger P, Freude G, Erdmann U (2001) Auditory probe sensitivity to mentalworkload changes—an event-related potential study. Int J Psychophysiol 40: 201–209.PubMedCrossRefGoogle Scholar
  57. Van der Meere JJ (2002) The role of attention. In: Sandberg S, ed. Monographs on Child and Adolescent Psychiatry. Hyperactivity Disorders, 2nd edn. Cambridge University Press, 162–213.Google Scholar
  58. Weglage J, Pietsch M, Fűnders B, Koch HG, Ullrich K (1996) Deficits in selective and sustained attention processes in early treated children with phenylketonuria—result of impaired frontal lobe functions? Eur J Pediatr 155: 200–204.PubMedCrossRefGoogle Scholar
  59. Weglage J, Oberwittler C, Marquardt T, et al (2000) Neurological deterioration in adult phenylketonuria. J Inherit Metab Dis 23: 83–83.PubMedGoogle Scholar
  60. Welsh MC, Pennington BF, Ozonoff S, Rouse B, McCabe ERB (1990) Neuropsychology of early treated phenylketonuria: specific executive function deficits. Child Dev 61: 1697–1713.PubMedGoogle Scholar
  61. Wickens C, Kramer A, Vanasse L, Donchin E (1983) Performance of concurrent tasks. A psychophysiological analysis of the reciprocity of information-processing resources. Science 221: 1080–1082.PubMedGoogle Scholar

Copyright information

© SSIEM and Springer 2005

Authors and Affiliations

  • J. R. Wiersema
    • 1
  • J. J. van der Meere
    • 1
    • 2
  • H. Roeyers
    • 1
  1. 1.Department of Experimental-Clinical and Health PsychologyGhent UniversityGhentBelgium
  2. 2.Department of Developmental and Experimental-Clinical PsychologyGroningen UniversityThe Netherlands

Personalised recommendations